Effect of almond-enriched high-monounsaturated fat diet on selected markers of inflammation: A randomised, controlled, crossover study

British Journal of Nutrition

Volumn 103, Issue 6, 2010, Pages 907-912

  Rajaram, Sujatha ^a   Connell, Kristianne M ^a   Sabaté, Joan ^a  

^a LOMA LINDA UNIVERSITY   (United States)

Author keywords

Almonds; CHD; Endothelial dysfunction; Haemostasis; Inflammation; Monounsaturated fat

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FIBRINOGEN; INTERLEUKIN 6; MONOUNSATURATED FATTY ACID; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID; TISSUE PLASMINOGEN ACTIVATOR ANTIGEN; UNCLASSIFIED DRUG; EDIBLE OIL; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ALMOND; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; ERYTHROCYTE MEMBRANE; FEMALE; HEART PROTECTION; HEMOSTASIS; HUMAN; HUMAN EXPERIMENT; INFLAMMATION; ISCHEMIC HEART DISEASE; MALE; NORMAL HUMAN; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; CALORIC INTAKE; DIET; MIDDLE AGED; NUT; PRUNUS;

PRUNUS DULCIS;

ADULT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CROSS-OVER STUDIES; DIET; DIETARY FATS, UNSATURATED; E-SELECTIN; ENERGY INTAKE; FATTY ACIDS, MONOUNSATURATED; FEMALE; FIBRINOGEN; HEMOSTASIS; HUMANS; INFLAMMATION; INTERLEUKIN-6; MALE; MIDDLE AGED; NUTS; PRUNUS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 77950361953     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114509992480     Document Type: Article

References (37)

1. Hanson GK (2005) Inflammation, atherosclerois, and coronary artery disease. N Engl J Med 352, 1685-1695.
2. Marx J (2004) Inflammation and cancer: the link grows stronger. Sci Tech Froid 306, 966-968.
3. Tedgui A & Mallat Z (2006) Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 86, 515-581.
4. Lichtenstein AH, Appel LJ, Brands M, et al. (2006) Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation 114, 82-96.
5. Kris-Etherton PM, Hu FB, Ros E, et al. (2008) The role of tree nuts and peanuts in the prevention of coronary heart disease: multiple potential mechanisms. J Nutr 138, 1746S-1751S.
6. Mukuddem-Petersen J, Oosthuizen W & Jerling J (2005) A systematic review of the effects of nuts on blood lipid profiles in humans. J Nutr 135, 2082-2089.
7. Griel AE & Kris-Ehterton PM (2006) Tree nuts and the lipid profile: a review of clinical studies. Br J Nutr 96, S68-S78.
8. Jiang R, Jacobs DR Jr, Mayer-Davis E, et al. (2006) Nut and seed consumption and inflammatory markers in the MultiEthnic Study of Atherosclerosis. Am J Epidemiol 163, 222-231.
9. Ros E (2008) Nuts: consumption, composition, health benefits and safety. CAB Rev 3, 1-12.
10. Blomhoff R, Carlsen MH, Frost AL, et al. (2006) Health benefits of nuts: potential role of antioxidants. Br J Nutr 96, S52-S60.
11. Wells BJ, Mainous AG & Everett CJ (2005) Association between dietay arginine and C-reactive protein. Nutrition 21, 125-130.
12. Jenkins DJA, Kendall CWC, Marchie A, et al. (2005) Direct comparison of dietary potfolio vs. statin on C-reactive protein. Eur J Clin Nutr 59, 851-860.
13. Estruch R, Martinez-González MA, Corella D, et al. (2006) Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial. Ann Intern Med 145, 1-11.
14. Sabaté J, Haddad E, Tanzman J, et al. (2003) Serum lipid response to the graduated enrichment of a step I diet with almonds: a randomized feeding trial. Am J Clin Nutr 77, 1379-1384.
15. Clauss A (1957) A Gerrinnungs physiologische schnell Methode zur Bestimmung des Fibrinogens. Acta Haematol 17, 237.
16. Holvoet P, Cleemput H & Collen D (1985) Assay of human tissue-type plasminogen activator [t-PA] with an enzyme-linked immunosorbent assay [ELISA] based on three murine monoclonal antibodies to t-PA. Thromb Haemostas 54, 684-697.
17. Macy E, Hayes T & Tracy R (1997) Variability in the measurement of C-reactive protein in healthy subjects: implication for reference interval and epidemiological applications. Clin Chem 43, 52-58.
18. Bonetti PO, Lerman LO & Lerman A (2003) Endothelial dysfunction: a marker of atherosclerotic risk. Thromb Vasc Biol 23, 168-175.
19. Bellido C, López-Miranda J, Pérez-Martinez P, et al. (2006) The Mediterranean and CHO diets decrease VCAM-1 and E-selectin expression induced by modified low-density lipoprotein in HUVECs. Nutr Metab Cardiovasc Dis 16, 524-530.
20. Perez-Jimenez F, Castro P, Lopez-Miranda J, et al. (1999) Circulating levels of endothelial function are modulated by dietary monounsaturated fat. Atherosclerosis 145, 351-358.
21. Rahman I, Biswas SK & Kirkham PA (2006) Regulation of inflammation and redox signaling by dietary polyphenols. Biochem Pharmacol 72, 1439-1452. (Pubitemid 44666744)
22. Chen CY, Milbury PE, Chung SK, et al. (2007) Effect of almond skin polyphenolics and quercetin on human LDL and apolipoprotein B-100 oxidation and conformation. Nutr Biochem 18, 785-794.
23. Jenkins DJA, Kendall CW, Marchie A, et al. (2002) Dose response of almonds on coronary heart disease risk factors: blood lipids, oxidized low-density lipoproteins, lipoprotein(a), homocysteine, and pulmonary nitric oxide: a randomized, controlled, crossover trial. Circulation 106, 1327-1332.
24. Song Y, Li TY, van Dam RM, et al. (2007) Magnesium intake and plasma concentrations of markers of systemic inflammation and endothelial dysfunction in women. Am J Clin Nutr 85, 1068-1074.
25. Huynh NN & Chin-Dusting J (2006) Amino acids, arginase and nitric oxide in vascular health. Clin Exp Pharmacol Physiol 33, 1-8.
26. Jambazian PR, Haddad E, Rajaram S, et al. (2005) Almonds in the diet simultaneously improve plasma alpha-tocopherol concentrations and reduce plasma lipids. J Am Diet Assoc 105, 449-454.
27. Meier-Ewert HD, Ridker PM, Rifai N, et al. (2001) Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects. Clin Chem 47, 426-430.
28. Temme EH, Mensink RP & Hornstra G (1999) Effects of diets enriched in lauric, palmitic or oleic acids on blood coagulation and fibroinolysis. Throb Haemost 81, 259-263.
29. Kris-Etherton PM & Dietschy J (1997) Design criteria for studies examining individual fatty acid effects on coronary heart disease risk factors: human and animal studies. Am J Clin Nutr 65, 1590S-1596S.
30. Browning LM, Krebs JD, Moore CS, et al. (2007) The impact of long chain n-3 poluunsaturated fatty acid supplementation on inflammation, insulin sensitivity and CVD risk in a group of overweight women with an inflammatory phenotype. Diabetes Obes Metab 9, 70-80.
31. Esposito K, Marfella R, Ciotola M, et al. (2004) Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. J Am Med Assoc 292, 1440-1446.
32. Kim YS, Young MR, Bobe G, et al. (2009) Bioactive food components, inflammatory targets, and cancer prevention. Cancer Prev Res (Phila Pa) 2, 200-208.
33. Montzoros CS, Williams CJ, Manson JE, et al. (2006) Adherence to the Mediterranean dietary pattern is positively associated with plasma adiponectin concentration in diabetic women. Am J Clin Nutr 84, 328-335.
34. Salas-Salvado J, Garcia-Arellano A, Estruch R, et al. (2008) Components of the Mediterranean-type food pattern and serum inflammatory markers among patients at high risk for coronary heart disease. Eur J Clin Nutr 62, 651-659.
35. Ros E, Nunez I, Perez-Heras A, et al. (2004) A walnut diet improves endothelial function in hypercholesterolemic subjects: a randomized crossover trial. Circulation 109, 1609-1614.
36. Mukuddem-Petersen J, Stonehouse Oosthuizen W, Jerling JC, et al. (2007) Effects of a high walnut and high cashew nut diet on selected markers of the metabolic syndrome: a controlled feeding trial. Br J Nutr 97, 1144-1153. (Pubitemid 46925367)
37. Hackam DC & Anand SS (2003) Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence. J Am Med Assoc 290, 932-940.